Panacos Pharmaceuticals Inc. to Present at Oppenheimer Small and Mid Cap Clinical and Regulatory Conference

WATERTOWN, Mass.--(BUSINESS WIRE)--Panacos Pharmaceuticals, Inc. (NASDAQ: PANC), a biotechnology company dedicated to developing the next generation of antiviral therapeutic products, will present at the Oppenheimer Small and Mid Cap Clinical and Regulatory Conference to be held on Monday, August 4, 2008. Alan W. Dunton, M.D., Panacos’ President and CEO, will present a corporate overview at 10:45 a.m. ET followed by a panel discussion titled “Panels, PDUFAs, and Planning For Commercialization” at 12:50 p.m. ET.